UMHS logo

RETURN TO PRESS RELEASE PAGE
link - UMHS HOME link UMHS HOME
Show Releases for 2001-2006 On:

  
Advanced Press Release Search      Advanced News Clip Search
Search Full Text of 2001-2006 Press Releases:
    
Help with Searching

November 29, 2004

NIH-NIAID awards Biodefense Proteomics Research Center contract to U-M Medical School to solve the puzzle of how anthrax infects its human host

Scientists will identify the bacterium’s weak points as new targets for drugs and vaccines

Contact information for:
JOURNALISTS & MEDIA


Information for:
PATIENTS, FAMILIES & HEALTH PROFESSIONALS


Radio news

Current UMHS Releases
Recent UMHS Releases

UMHS in the media

UM main campus news

Subscribe to online UMHS newsletter

 

ANN ARBOR, MI - The University of Michigan Medical School has been awarded a $5.9-million, five-year contract from the National Institute of Allergy and Infectious Diseases (NIAID) to create a comprehensive inventory of genes and proteins active in Bacillus anthracis, the bacterium that causes anthrax, as it infects its human host.

Philip Hanna, Ph.D.The U-M Center is one of seven new NIH-funded Biodefense Proteomics Research Centers that will study biodefense-related pathogens or pathogens responsible for emerging and re-emerging diseases.

“Our objective is to use global proteomics- and genomics-based approaches to document gene expression patterns during all phases of the B. anthracis lifecycle, but especially at the earliest stages of infection,” says Philip Hanna, Ph.D., the director of the U-M Center and an assistant professor of microbiology and immunology in the Medical School.

“We anticipate that our work will provide the first detailed characterization of specific elements in the bacterium and host that are essential for anthrax infection,” says Hanna. “Identifying the bacterium's weak points will provide targets for rapid diagnosis and the development of more effective drugs and vaccines to prevent anthrax infection or minimize its effects.”

“One of the goals of the center is to integrate the data into a central database that will be available to other scientists around the country,” says Nicholas Bergman, Ph.D., co-director of the Center and a research investigator in bioinformatics in the U-M Medical School. “This resource should be very useful to investigators who are developing new drugs and vaccines.” Bergman is a member of the NIAID committee charged with developing databases to store data from each research center.

The U-M team will collaborate with John Yates III, Ph.D., of The Scripps Research Institute in La Jolla, Calif. Scientists at the Scripps Institute will use advanced proteomics analysis techniques, which they developed and are required for the study, while U-M scientists focus on microbial pathogenesis, as well as anthrax and host genomics.

For more information on the NIH Biodefense Proteomics Research Centers:
http://www.niaid.nih.gov/dmid/genomes/prc/default.htm

To learn more about U-M research on anthrax:
http://www.med.umich.edu/opm/newspage/2004/anthrax.htm
http://www.med.umich.edu/opm/newspage/2003/anthraxspores.htm

Written by Sally Pobojewski


E-mail this information to a friend

Recent Press Releases

 


U-M Medical School
| Hospitals & Health Centers | U-M | TEXT-ONLY

University of Michigan Health System
1500 E. Medical Center Drive  Ann Arbor, MI 48109   734-936-4000
(c) copyright 2008 Regents of the University of Michigan
Developed & maintained by: Public Relations & Marketing Communications
Contact UMHS

 U.S. News and World Reports: America's Best Hospitals 2006
The University of Michigan Health System web site does not provide specific medical advice and does not endorse any medical or professional service obtained through information provided on this site or any links to this site.
Complete disclaimer and Privacy Statement

UMHS HOME

Health Topics A-Z

For Patients & Families

For Health Professionals

Search Tools & Index